Back to results
US 2022/0186288 A1Published application
Method for validating assays of biological samples
AssigneeThe Translational Genomics Research Institute
InventorsTimothy K. McDaniel, Muhammed Murtaza
Life of this patent
Estimating the term…
Abstract
The invention provides a method for validating patient-specific oligos using spike-in sequences.
Claims22
1-20. (canceled)
A method of validating a patient-specific oligo, the method comprising:
- extracting DNA or RNA from a patient sample to produce a DNA or RNA sample;
- introducing a plurality of sets of spike-in sequences into the DNA or RNA sample to produce a spiked sample, wherein the plurality of sets of spike-in sequences comprises spike-in sequences of known concentrations;
- assaying the spiked sample with synthesis-control oligos and patient-specific oligos to produce a read out of the counts of the set of spike-in sequences and detect the patient-specific RNA or DNA;
- and
- comparing the counts from the set of spike-in sequences with the known concentrations of the spike-in sequences to provide dose-response characteristics of the synthesis control oligos which thereby serve as proxies for the dose-response characteristics of the patient-specific oligos.
2 more elements
Dependencies are inferred from the claim text.